NCT06631261

Brief Summary

Individuals with bronchiectasis exhibit productive cough and recurrent lung infections as well as reduced exercise capacity, physical activity level, and respiratory and peripheral muscle strength. 6-minute walk test (6MWT) is often used to assess exercise capacity in chronic lung diseases. 6MWT is recommended to be performed along a flat corridor, at least 30 m long, with low pedestrian traffic, on a hard surface. To overcome technical limitations during 6MWT, 6-minute stepper test (6MST) has been proposed to assess exercise capacity. Another test that provides information about exercise capacity is the 1-minute sit-to-stand test (1STS). To our knowledge, there is limited information about different exercise tests including 6MST and 1STS and cardiopulmonary responses to these tests in individuals with bronchiectasis. Therefore, this study aims to compare the responses to the 6MST between individuals with bronchiectasis and healthy controls and to investigate the relationships among 6MST, 6MWT, and 1STS responses and muscle strength.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Sep 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 18, 2024

Completed
16 days until next milestone

First Submitted

Initial submission to the registry

October 4, 2024

Completed
4 days until next milestone

First Posted

Study publicly available on registry

October 8, 2024

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 18, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 18, 2026

Completed
Last Updated

October 8, 2024

Status Verified

October 1, 2024

Enrollment Period

1.3 years

First QC Date

October 4, 2024

Last Update Submit

October 7, 2024

Conditions

Keywords

BronchiectasisExercise Capacity

Outcome Measures

Primary Outcomes (6)

  • Maximal inspiratory pressure

    Maximal inspiratory pressure (MIP) and will be measured using aa mouth-piece pressure measurement device. The measurement will be repeated three times so that there will be no difference of 10 cmH₂O or 10%, and the highest value will be used for analysis.

    1st day

  • Maximal expiratory pressure

    Maximal expiratory pressure (MEP) and will be measured using a mouth-piece pressure measurement device. The measurement will be repeated three times so that there will be no difference of 10 cmH₂O or 10%, and the highest value will be used for analysis.

    1st day

  • Peripheral muscle strength

    Peripheral muscle strength will be assessed using a portable dynamometer. The peripheral muscle strength test will be repeated three times for the right and left sides.

    1st day

  • 6-minute stepper test responses

    6-minute stepper test will be performed, and the number of repetitions will be recorded. Cardiopulmonary responses before and after 6-minute stepper test will be recorded. 6-minute stepper test will be performed twice with 30 minutes apart.

    1st day

  • 1 minute sit-to-stand test responses

    1 minute sit-to-stand test will be performed and the repetitions will be recoded. Cardiopulmonary responses will be recorded before and after the test.

    1 minute sit-to-stand test will be performed and the repetitions will be recoded. Cardiopulmonary responses will be recorded before and after the test.

  • 6-minute walk test responses

    6-minute walk test will be performed, and the distance walked will be recorded. Cardiopulmonary responses before and after 6-minute walk test will be recorded.

    1st day

Secondary Outcomes (8)

  • Dyspnea

    1st day

  • Charlson Comorbidity Index

    1st day

  • Bronchiectasis Severity Index

    1st day

  • Forced vital capacity

    1st day

  • Forced expiratory volume in one second

    1st day

  • +3 more secondary outcomes

Study Arms (2)

Bronchiectasis

Individuals with bronchiectasis

Other: No intervention; Observational study

Healthy controls

Other: No intervention; Observational study

Interventions

No intervention

BronchiectasisHealthy controls

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Individuals with bronchiectasis and healthy controls

You may qualify if:

  • Being 18 years of age and older,
  • Having a clinically stable bronchiectasis,
  • To cooperate with the tests to be performed,
  • Not having a cardiovascular disease, orthopedic or neurological problem that may affect the tests,
  • Being willing to participate in the study.

You may not qualify if:

  • Being in an acute exacerbation period,
  • Having a cardiovascular, orthopedic or neurological problem that may affect the tests,
  • Not being willing to participate in the study.
  • Being 18 years of age and older,
  • To cooperate with the tests to be performed,
  • Not having a cardiovascular, orthopedic or neurological problem that may affect the tests,
  • Being willing to participate in the study.
  • \- Individuals with any known internal disease and those who do not volunteer to participate in the study will not be included in the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hacettepe University Faculty of Physical Therapy and Rehabilitation

Ankara, Ankara, 06100, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

Bronchiectasis

Interventions

Observation

Condition Hierarchy (Ancestors)

Bronchial DiseasesRespiratory Tract Diseases

Intervention Hierarchy (Ancestors)

MethodsInvestigative Techniques

Central Study Contacts

Aslihan Cakmak-Onal Study Principal Investigator, PhD, PT

CONTACT

Elif Kocaaga, MSc, PT

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

October 4, 2024

First Posted

October 8, 2024

Study Start

September 18, 2024

Primary Completion

January 18, 2026

Study Completion

January 18, 2026

Last Updated

October 8, 2024

Record last verified: 2024-10

Data Sharing

IPD Sharing
Will not share

Locations